Form 4: Natural Alternatives International CEO Mark Ledoux Reports Stock Transactions

Sentiment:

SEC Form 4 Filing


Mark Ledoux, CEO and Chairman of Natural Alternatives International, reports the acquisition and disposal of company stock related to tax liabilities and a restricted stock grant.

Summary

  • On March 7, 2024, Mark Ledoux disposed of 5,777 shares of common stock to cover tax liabilities upon the vesting of 13,666 restricted shares.
  • The shares were sold back to the issuer at a price of $5.95 per share.
  • On March 8, 2024, Ledoux acquired 17,000 shares of restricted stock under the company's 2020 Omnibus Incentive Plan.
  • These restricted shares will vest in three equal installments on March 7, 2025, March 7, 2026, and March 7, 2027.
  • Following these transactions, Ledoux directly owns 166,121 shares of common stock.
  • Ledoux also indirectly owns 481,905 shares through the LeDoux Family Limited Partnership, 69,416 shares through an IRA, 7,200 shares as custodian for Marcelle Jeannette LeDoux, 800 shares as custodian for Jean-Marc Emile LeDoux, and 7,500 shares as custodian for Aimee LeDoux.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The transactions are routine and related to stock-based compensation. There is no indication of unusual activity or concern.

Positives

  • The grant of restricted stock to the CEO aligns his interests with the long-term performance of the company.
  • The vesting schedule of the restricted stock encourages long-term commitment from the CEO.

Future Outlook

The CEO's future stock ownership will be influenced by the vesting of the restricted stock granted on March 8, 2024, over the next three years.

Industry Context

Insider transactions are routinely monitored by investors as they can provide insights into management's perspective on the company's valuation and future prospects. The vesting of restricted stock is a common practice to align management's interests with shareholders.

Comparison to Industry Standards

  • Stock-based compensation is a common practice in the industry to incentivize executives.
  • Vesting schedules are typically structured over a multi-year period to promote long-term commitment.
  • Companies like Herbalife Nutrition and USANA Health Sciences also utilize stock options and restricted stock units as part of their executive compensation packages.

Stakeholder Impact

  • The transactions have a minimal direct impact on stakeholders.
  • The stock grant aligns management's interests with shareholders, which can be viewed positively.

Key Dates

DateDescription
03/07/2024Disposal of 5,777 shares for tax liability and vesting of 13,666 restricted shares.
03/08/2024Grant of 17,000 restricted stock units.
03/07/2025First vesting date for 5,667 restricted shares.
03/07/2026Second vesting date for 5,667 restricted shares.
03/07/2027Final vesting date for 5,666 restricted shares.
03/11/2024Date of signature for the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.